Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-062222
Filing Date
2025-05-01
Accepted
2025-05-01 21:19:59
Documents
2
Period of Report
2024-12-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4635
2 EX-24 ck0001559053-ex24.htm EX-24 13752
  Complete submission text file 0000950170-25-062222.txt   20091
Mailing Address C/O MCGRATH DOYLE & PHAIR 150 BROADWAY NEW YORK NY 10038
Business Address
SCULLY WILLIAM P (Reporting) CIK: 0001045463 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 25905208

Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)